Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fitbit’s wearable devices are commercially available worldwide. The company has received FDA clearance for its photoplethysmography-based atrial fibrillation detection algorithm. Its products have been validated in clinical studies for heart rate accuracy and arrhythmia screening. The ecosystem includes population-scale digital health programs with demonstrated user engagement but does not include traditional drug development or clinical trial pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fitbit.